Srinivas Rao - Mar 2, 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Co-Founder & Chief Scientific Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact for Srinivas Rao
Stock symbol
ATAI
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 02:56 PM
Previous filing
Jun 24, 2021
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +1.31M $0.00 1.31M Mar 2, 2022 Common Shares 1.31M $2.44 Direct F1
transaction ATAI Stock Option Award $0 +840K $0.00 840K Mar 2, 2022 Common Shares 840K $2.44 Direct F2
transaction ATAI Stock Option Award $0 +519K $0.00 519K Mar 2, 2022 Common Shares 519K $5.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and is exercisable as to 25% of the underlying shares on April 1, 2020, and as to 2.083% of the underlying shares in 36 monthly installments commencing on May 1, 2020.
F2 The stock option vests and is exercisable as to 25% of the underlying shares on August 21, 2021, and as to 2.083% of the underlying shares in 36 monthly installments commencing on September 1, 2021.
F3 The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

Remarks:

Co-Founder & Chief Scientific Officer